Back

Trends in incidence and mortality from non-rheumatic degenerative mitral valve disease across europe, over the past three decades.

27 August 2021 (20:24 - 20:33)
Organised by:
Congress Presentation Part of: A deep dive into mitral regurgitation Epidemiology, Prognosis, Outcome ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Doctor Becker Al-khayatt

Guy's and St Thomas' NHS Trust Hospitals, London (United Kingdom of Great Britain & Northern Ireland)

4 More presentations in this session

Presentation thumbnail
Circulating transforming growth factor-beta1 and progression of the mitral valve prolapse: fifteen-year follow-up
Professor E. Malev (Saint Petersburg, RU)
Abstract Slides Video
Presentation thumbnail
The MIDA Quantitative mortality risk score: prognostic model in floppy mitral valves
Doctor B. Essayagh (Cannes, FR)
Abstract Slides Video
Presentation thumbnail
Myocardial efficiency in severe asymptomatic primary mitral regurgitation: relation to quantitative measures of regurgitation
Professor J. Sorensen (Uppsala, SE)
Abstract Slides Video
Presentation thumbnail
Clinical and haemodynamic effects of percutaneous edge-to-edge mitral valve repair in atrial versus ventricular functional mitral regurgitation
Professor M. Claeys (Antwerp, BE)
Abstract Slides Video

Access the full session

Session thumbnail
A deep dive into mitral regurgitation

The Event

Event poster

ESC Congress 2021 - The Digital Experience

27 August 2021 20:24 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources